ΕΠΙΚΟΙΝΩΝΙΑ

ΚΑΙΝΟΤΟΜΙΑ.
ΔΟΜΙΚΟΣ ΠΥΛΩΝΑΣ ΑΝΑΠΤΥΞΗΣ

Όλες οι Αιτήσεις & τα Διπλώματα ΕυρεσιτεχνίαςΌλες οι Δημοσιευμένες Επιστημονικές εργασίες Όλες οι παρουσιάσεις σε Εθνικά & Διεθνή Συνέδρια

Η Ιουλία Τσέτη διακρίνεται ανάμεσα στον επιχειρηματικό κόσμο -και όχι μόνο, για την έμφαση που δίνει στον όρο «Καινοτομία». Οι Εταιρείες του ΟΦΕΤ έχουν σειρά διακρίσεων τόσο για τον τρόπο που λειτουργούν όσο και για τα προϊόντα που παράγουν, ενώ, επιπρόσθετα, η ίδια αναφέρεται στις ομιλίες και συζητήσεις της στο πλαίσιο των δράσεών της στον όρο «Καινοτομία», ως την βασική παράμετρο αναχαίτισης της επιστημονικής μεταναστευτικής αιμορραγίας και ως δομικού πυλώνα για την επιχειρηματική και βιομηχανική ισχυροποίηση της Ελλάδας.

41

Επιστημονικες
Εργασιες

24

Παρουσιασεις
σε συνεδρια

100

Ευρωπαϊκες/Διεθνεις
Αιτησεις-Διπλωματα
Ευρεσιτεχνιας

Ως αποτέλεσμα αυτής της στρατηγικής της έμφασης, η ίδια ή / και ο ΟΦΕΤ, σήμερα μετρούν:

  • την ιδιοκτησία 100 Ιστορικών Διπλωμάτων (Εθνικές Αιτήσεις/Διπλώματα Ευρεσιτεχνίας) ως εφευρέτης/καταθέτης ως φυσικό πρόσωπο ή με την ιδιότητά της ως νόμιμη εκπρόσωπος των εταιρειών του ΟΦΕΤ
  • 41 Επιστημονικές εργασίες δημοσιευμένες σε επιστημονικά περιοδικά / βιβλία με κριτές
  • 24 Προφορικές & Αναρτημένες παρουσιάσεις σε Εθνικά & Διεθνή Συνέδρια

Από το 2018 έως και το 2023, ο ΟΦΕΤ έχει χρηματοδοτήσει με ίδιους πόρους πάνω από 45 εσωτερικά ερευνητικά προγράμματα, τα οποία εκπονούνται σε συνεργασία με εγχώρια Ακαδημαϊκά και Ερευνητικά Ιδρύματα, ενώ 28 ερευνητικά προγράμματα έχουν χρηματοδοτηθεί υπό μορφή χορηγιών & υποτροφιών από το Ίδρυμα ΑΜΚΕ «ΚΛΕΩΝ ΤΣΕΤΗΣ». Επίσης, κατά το ίδιο χρονικό διάστημα, ο ΟΦΕΤ έχει συμμετάσχει ως βιομηχανικός εταίρος με ιδιωτική συμμετοχή σε 10 εθνικά/διεθνή ερευνητικά προγράμματα συγχρηματοδοτούμενα μέσω της Γενικής Γραμματείας Έρευνας και Καινοτομίας (ΓΓΕΚ).

Ο Όμιλος Φαρμακευτικών Επιχειρήσεων Τσέτη, εκπόνησε επίσης μέσα στο πρώτο εξάμηνο του 2022, 28 ερευνητικά προγράμματα. Τα 8 από αυτά είναι συγχρηματοδοτούμενα με τη Γενική Γραμματεία Έρευνας και Καινοτομίας (ΓΓΕΚ) και τα 12 αφορούν άμεσα, ή έμμεσα, στην αξιοποίηση της βιοποικιλότητας της χώρας. Ήδη από την έναρξη του ακαδημαϊκού έτους 2022-2023, ο Όμιλος ΟΦΕΤ ξεκίνησε την εκπόνηση επιπλέον 5 καινούριων ερευνητικών προγραμμάτων, τα οποία προστέθηκαν στα ήδη τρέχοντα. Τα προγράμματα υλοποιούνται σε συνεργασία με Ακαδημαϊκά και Ερευνητικά Ιδρύματα.

Την 1η Ιουνίου 2022 επίσης, η διοίκηση του Ομίλου ανακοίνωσε συνεργασίες αιχμής στον τομέα της βιοτεχνολογίας με δύο κορυφαία Ινστιτούτα της χώρας: το Ινστιτούτο Μοριακής Βιολογίας και Βιοτεχνολογίας στην Κρήτη και το Ινστιτούτο Βιοϊατρικής Έρευνας στα Ιωάννινα. Και τα δύο Ινστιτούτα βρίσκονται υπό την ομπρέλα του Ιδρύματος Τεχνολογίας και Έρευνας.

Η κυρία Ιουλία Τσέτη, επισημαίνει, ότι «η συνεργασία με τα δύο Ινστιτούτα του Ιδρύματος Τεχνολογίας και Έρευνας θα έχει αμοιβαία οφέλη τόσο για το ίδιο το ΙΤΕ όσο και για τον ΟΦΕΤ, με κοινό στόχο την προαγωγή της εφαρμοσμένης έρευνας και της καινοτομίας, η οποία θα προέρχεται αμιγώς από ερευνητικά Ινστιτούτα με έδρα την Ελληνική περιφέρεια». Υπογραμμίζει ακόμη, ότι «στην Ελλάδα παράγεται βασική έρευνα, την οποία οι επιχειρήσεις θα πρέπει να υποστηρίξουν, με στόχο οι νέοι επιστήμονες να παραμείνουν στη χώρα μας και ταυτόχρονα να δώσουμε την ελπίδα σε όσους επιθυμούν, να ακολουθήσουν το ερευνητικό πεδίο προκειμένου η Ελλάδα να μεταμορφωθεί σε Κόμβο Καινοτομίας και Αριστείας».

ΕΥΡΩΠΑΪΚΕΣ/ΔΙΕΘΝΕΙΣ ΑΙΤΗΣΕΙΣ-ΔΙΠΛΩΜΑΤΑ ΕΥΡΕΣΙΤΕΧΝΙΑΣ

Ευρωπαϊκές/Διεθνείς Αιτήσεις-Διπλώματα Ευρεσιτεχνίας ως εφευρέτης/καταθέτης, ως φυσικό πρόσωπο ή με την ιδιότητά της ως νόμιμη εκπρόσωπος των εταιρειών του ΟΦΕΤ

2024
  • Pharmaceutical composition of paracetamol in a water-soluble form in a hermetically sealed container for preparing a hot beverage
2023
  • 4-(2-(4-((2,4-dioxothiazolidin-5-yl)methyl)phenoxy) derivatives and their (bio)isosteres as PPARγ agonists and autotaxin inhibitors
2022
  • Lyotropic liquid crystalline nanosystems with encapsulated bioactive macromolecules
2021
  • Nutritional supplement, suitable for oral administration, comprising dihydromyricetin, choline and one or more vitamins with antioxidant activity, for use in the maintenance of normal liver function
  • Pharmaceutical composition comprising l-triiodothyronine (Τ3) for use in the treatment of tissue hypoxia and sepsis
  • Thieno[3,4-c]pyrazol-3-yl acetamides as autotaxin inhibitors
2020
  • Olive fruit extract suitable for reducing body-mass index and visceral fat in overweight subjects
2019
  • A pharmaceutical composition for the treatment of anemia in a suitable container, which keeps the active ingredients separated in a sealed manner: the ferric complex with N-acetyl-L-aspartic casein and calcium folinate pentahydrate 
  • A pharmaceutical composition for enhancing iron levels in blood, comprising iron (III) polymaltose and another active substance, suitable for iron absorption, selected from calcium folinate pentahydrate, vitamin C or a combination of both 
  • Composition, in the form of a soft capsule, comprising a combination of extracts from olive fruit, Red Yeast Rice and Crocus Sativus L. and method of preparing the same 
  • Dry powder thyroid hormone drug preparations for inhaled administration 
  • Dietary supplement, in the form of a single-dose oral solution, comprising magnesium, melatonin, tryptophan and 5-hydroxytryptophan, useful to reduce the time until onset of sleep 
  • Nutritional supplement, suitable for oral administration, comprising lactoferrin, xyloglucan, proanthocyanidins and simethicone for the joint prevention of gastrointestinal and urinary tract infections 
  • L-triiodothyronine (T3) for use in limiting microvascular obstruction
2015
  • Stable pharmaceutical dosage forms comprising levothyroxine sodium
  • Skin cleansing compositions
  • Ιron (III) hydroxide complexes with activated glucose syrups and process for preparing same
  • A process for producing iron (III) casein N-acetyl-aspartylated complexes and use thereof in pharmaceutical compositions
2014
  • Topical pharmaceutical and medical device preparations containing combinations of sucralfate, hyaluronic acid, arginine and a natural moisturizing agent
  • Assembly adapted for dispensing food supplement compositions into a container
2012
  • Pharmaceutical composition comprising (S)-2-(2-oxoryrrolidin-1-yl) butanamid 
2009
  • Effervescent formulations comprising a phosphonate and methods for their preparation 
  • Stable ready to use injectable paracetamol formulation
2008
  • Effervescent tablets and effervescent granules containing carnitine tartrate
2005
  • Medicaments for Alzheimer
  • Stable pharmaceutical gel of diclofenac sodium
2004
  • Dry powder comprising levothyroxine sodium administrated via inhalator
2001
  • Parenteral composition of Paracetamol
  • Stable pharmaceutical solutions of nimesulide
1997
  • Pharmaceutical injectable solutions containing paracetamol and combinations of paracetamol with other active substances
Διαβάστε Περισσότερα

ΔΗΜΟΣΙΕΥΜΕΝΕΣ ΕΠΙΣΤΗΜΟΝΙΚΕΣ ΕΡΓΑΣΙΕΣ

Επιστημονικές εργασίες δημοσιευμένες σε επιστημονικά περιοδικά/βιβλία με κριτές

  1. Kikionis, S.; Iliou, K.; Karra, A.G.; Polychronis, G.; Choinopoulos, I.; Iatrou, H.; Eliades, G.; Kitraki, E.; Tseti, I.; Zinelis, S.; et al. Development of Bi- and Tri-Layer Nanofibrous Membranes Based on the Sulfated Polysaccharide Carrageenan for Periodontal Tissue Regeneration. Mar. Drugs 2023, 21, 565. https://doi.org/10.3390/md21110565
  2. Renieris G., Foutadakis S., Andriopoulou T., Spanou V.-M., Droggiti D.-E., Kafousopoulos D., Gkavogianni T., Damoraki G., Vatsellas G., Giamarellos-Bourboulis E.J. Association of Vitamin D with severity and outcome of COVID-19: Clinical and Experimental Evidence. Journal of Innate Immunity 2023,16(1), 1-11. doi: 10.1159/000535302
  3. Kotanidou, E.P.; Tsinopoulou, V.R.; Giza, S.; Ntouma, S.; Angeli, C.; Chatziandreou, M.; Tsopelas, K.; Tseti, I.; Galli-Tsinopoulou, A. The Effect of Saffron Kozanis (Crocus sativus L.) Supplementation on Weight Management, Glycemic Markers and Lipid Profile in Adolescents with Obesity: A Double-Blinded Randomized Placebo-Controlled Trial. Children 2023, 10, 1814. https://doi.org/10.3390/children10111814
  4. Iakovis N, Ikonomidis I, Andreadou I, Xanthopoulos Α, Chamaidi A, Chrysakis N, Giamouzis G, Skoularigis J, Tseti I, Triposkiadis F. The Short-Term Effect of Olive Oil Extract Enriched with Hydroxytyrosol on Cardiovascular Function. J Med Food. 2023 Nov 15. doi: 10.1089/jmf.2023.0129
  5. Zerikiotis S, Efentakis P, Dapola D, Agapaki A, Seiradakis G, Kostomitsopoulos N, Skaltsounis AL, Tseti I, Triposkiadis F, Andreadou I. Synergistic Pulmonoprotective Effect of Natural Prolyl Oligopeptidase Inhibitors in In Vitro and In Vivo Models of Acute Respiratory Distress Syndrome. Int J Mol Sci. 2023 Sep 18;24(18):14235. doi: 10.3390/ijms241814235.
  6. Antoniadou I, Georgiou M, Dotsikas Y, Lamprou A, Lougiakis N, Pouli N, Karousis N, Loukas Y, Tseti I, Marakos P, Papapetropoulos A. Novel H2S-Releasing Bifunctional Antihistamine Molecules with Improved Antipruritic and Reduced Sedative Actions. J Med Chem. 2023 Jul 27;66(14):9607-9621. doi: 10.1021/acs.jmedchem.3c00321
  7. Panagiotou, D.; Filidou, E.; Gaitanidou, M.; Tarapatzi, G.; Spathakis, M.; Kandilogiannakis, L.; Stavrou, G.; Arvanitidis, K.; Tsetis, J.K.; Gionga, P.; Shrewsbury, A.D.; Manolopoulos, V.G.; Kapoukranidou, D.; Lasithiotakis, K.; Kolios, G.; Kotzampassi, K. Role of Lactiplantibacillus plantarum UBLP-40, Lactobacillus rhamnosus UBLR-58 and Bifidobacterium longum UBBL-64 in the Wound Healing Process of the Excisional Skin. Nutrients 2023, 15, 1822. https://doi.org/10.3390/nu15081822
  8. Ikonomidis I, Katogiannis K, Chania C, Iakovis N, Tsoumani M, Christodoulou A, Brinia E, Pavlidis G, Thymis J, Tsilivarakis D, Kountouri A, Korakas E, Lambadiari V, Triposkiadis F, Skaltsounis L, Tseti I, Iliodromitis EK, Andreadou I. Association of hydroxytyrosol enriched olive oil with vascular function in chronic coronary disease. Eur J Clin Invest. 2023 Mar 13:e13983. DOI: 10.1111/eci.13983
  9. M. Tsilika, J. Mitrou, N. Antonakos, I.K. Tseti, G. Damoraki, K. Leventogiannis & E.J. Giamarellos-Bourboulis. An active new formulation of iron carried by aspartyl casein for iron-deficiency anemia: results of the ACCESS trial Annals of Hematology 2023 Jun;102(6):1341-1349. DOI: 10.1007/s00277-023-05197-3
  10. V.-K. Bournia, G., Fragoulis, P. Mitrou, K. Mathioudakis, A. Tsolakidis, G. Konstantonis, I. Tseti, G. Vourli, M. G Tektonidou, D. Paraskevis, P. P. Sfikakis, Different Covid-19 Outcomes Among Systemic Rheumatic Diseases: A Nation-wide Cohort Study, Rheumatology, 2023, 1;62(3):1047-1056,https://doi.org/10.1093/rheumatology/keac422
  11. Kostaki EG, Mossialos E, Tseti I, Sfikakis PP, Paraskevis D. Mapping the Early Dispersal Patterns of SARS-CoV-2 Omicron BA.4 and BA.5 Subvariants in the Absence of Travel Restrictions and Testing at the Borders in Europe. Viruses. 2022 Dec 31;15(1):133. doi: 10.3390/v15010133. DOI: 10.3390/v15010133
  12. Kopsidas I, Karagiannidou S, Kostaki EG, Kousi D, Douka E, Sfikakis PP, Moustakidis S, Kokkotis C, Tsaopoulos D, Tseti I, Zaoutis T, Paraskevis D. Global Distribution, Dispersal Patterns, and Trend of Several Omicron Subvariants of SARS-CoV-2 across the Globe. Trop Med Infect Dis. 2022 Nov 12;7(11):373. DOI: 10.3390/tropicalmed7110373
  13. F. Ntziora, E.G. Kostaki, A. Karapanou, M. Mylona, I. Tseti, N. V. Sipsas, D. Paraskevis, P.P. Sfikakis. Protection of vaccination versus hybrid immunity against infection with COVID-19 Omicron variants among Health-Care Workers, Vaccine, 2022, 40 (50) 7195-7200 https://doi.org/10.1016/j.vaccine.2022.09.042
  14. Mourouzis, I.; Apostolaki, V.; Trikas, A.; Kokkinos, L.; Alexandrou, N.; Avdikou, M.; Giannoulopoulou, M.; Vassi, A.; Tseti, I.; Pantos, C. The potential of thyroid hormone therapy in severe COVID-19: Rationale and preliminary evidence. Int. J. Environ. Res. Public Health 2022, 19, 8063, https://doi.org/10.3390/ijerph19138063.
  15. V.-K. Bournia, G., Fragoulis, P. Mitrou, K. Mathioudakis, A. Tsolakidis, G. Konstantonis, I. Tseti, G. Vourli, M. G Tektonidou, D. Paraskevis, P. P. Sfikakis, Different Covid-19 Outcomes Among Systemic Rheumatic Diseases: A Nation-wide Cohort Study, Rheumatology, 2022, keac422,https://doi.org/10.1093/rheumatology/keac422
  16. C. Fytili, T. Nikou, N. Tentolouris, I. K. Tseti, C.S Dimosthenopoulos, P. P. Sfikakis, D. Simos, A. Kokkinos, L. A. Skaltsounis, N. Katsilambros, M. Halabalaki. Effect of Long-Term Hydroxytyrosol Administration on Body Weight, Fat Mass and Urine Metabolomics: A Randomized Double-Blind Prospective Human Study Nutrients, 2022, 14, 1525, https://doi.org/10.3390/nu14071525
  17. Chountoulesi, M.; Pispas, S.; Tseti, I.K.; Demetzos, C. Lyotropic Liquid Crystalline Nanostructures as Drug Delivery Systems and Vaccine Platforms. Pharmaceuticals 2022, 15, 429. https://doi.org/10.3390/ph15040429
  18. Tsoumani, M.; Nikolaou, P.E.; Argyropoulou, A.; Tseti, I.; Mitakou, S.; Andreadou, I. Novel Evidence-Based Combination of Plant Extracts with Multitarget Mechanisms of Action for the Elimination of Hot Flashes during Menopause. Molecules 2022, 27, 1221. https://doi.org/10.3390/molecules27041221
  19. M. Moysidis, G. Stavrou, A. Cheva, I. Abba Deka, J. K. Tsetis, V. Birba, D. Kapoukranidou, A. Ioannidis, G. Tsaousi, K. Kotzampassi. The 3-D configuration of excisional skin wound healing after topical probiotic application Injury, 2022, 53, 1385, https://doi.org/10.1016/j.injury.2022.02.006
  20. N. Viazis, K. Argyrios, K. Kotzampassi, D. Christodoulou, P. Apostolopoulos, S. D Georgopoulos, C. Liatsos, O. Giouleme, K. Koustenis, C. Veretanos, D. Stogiannou, M. Moutzoukis, C. Poutakidis, I. Mylonas, I. Tseti, G. J. Mantzaris. Α four-probiotics regimen combined with a standard helicobacter pylori eradication treatment reduces side effects and increases eradication rates. Nutrients, 2022, 14, 632; https://doi.org/10.3390/nu14030632.
  21. Lourbopoulos, A.I.; Mourouzis, I.S.; Trikas, A.G.; Tseti, I.K.; Pantos, C.I. Effects of Thyroid Hormone on Tissue Hypoxia: Relevance to Sepsis Therapy. J. Clin. Med. 2021, 10, 5855. https://doi.org/10.3390/jcm10245855
  22. E. G. Kostaki, I. Tseti, S. Tsiodras, G. N. Pavlakis, P. P. Sfikakis, D. Paraskevis, Temporal Dominance of B.1.1.7 over B.1.354 SARS-CoV-2 Variant: A Hypothesis Based on Areas of Variant Co-Circulation. Life 2021, 11(5), 375; https://doi.org/10.3390/life11050375
  23. I. S. Mourouzis, A. I. Lourbopoulos, A. G. Trikas, I. K. Tseti, C. I. Pantos. Triiodothyronine prevents tissue hypoxia in experimental sepsis: potential therapeutic implications. Intensive Care Medicine Experimental 2021, volume 9, Article number: 17; https://doi.org/10.1186/s40635-021-00382-y
  24. Christodoulou A, Tsoumani M, Nikolaou PE, Efentakis P, Kostomitsopoulos N, Dimitriou C, Halabalaki M, Tseti I, Skaltsounis AL, Iliodromitis E, Andreadou I. Comparative Study of the cardioprotective effect exerted by bioactive compounds found in olives and olive oil in a mouse model of metabolic syndrome” J. Atherosclerosis Prev Treat. 2021 Supplement 1;12:6. DOI:10.1093/eurheartj/ehab724.2428
  25. A Christodoulou, P E Nikolaou, M Tsoumani, P Efentakis, N Kostomitsopoulos, C Dimitriou, I Ikonomidis, M Halabalaki, I Tseti, A L Skaltsounis, E Iliodromitis, I Andreadou, Comparative study of the bioactive compounds of olive products on cardioprotection from ischemia-reperfusion injury in mice with metabolic syndrome, European Heart Journal, Volume 42, Issue Supplement_1, October 2021, ehab724.2428 doi: 10.1093/eurheartj/ehab724.2428
  26. M Tsoumani, A Georgoulis, P E Nikolaou, I Kostopoulos, T Dermintzoglou, I Papatheodorou, A Zoga, P Efentakis, A Papapetropoulos, A Lazou, A L Skaltsounis, O Tsitsilonis, I Tseti, E K Iliodromitis, I Andreadou, Acute administration of the olive constituent, oleuropein, combined with post-conditioning mechanism exerts cardioprotective effects by modulating oxidative defense, European Heart Journal, Volume 42, Issue Supplement 1, October 2021, ehab724.3240, https://doi.org/10.1093/eurheartj/ehab724.3240
  27. T. Nikou, C. Fytili, E. Kalampokis, N. Tentolouris, I. K. Tseti, L.A. Skaltsounis, M. Halabalaki. New human urine biomarkers associated with hydroxytyrosol consumption and olive-based products. Planta Med 2021; 87(15): 1244 https://doi.org/10.1055/s-0041-1736763
  28. M. Tsoumani, A. Georgoulis, P.-E. Nikolaou, I. V. Kostopoulos, T. Dermintzoglou, I. Papatheodorou, A. Zoga, P. Efentakis, M. Konstantinou, E. Gikas, N. Kostomitsopoulos, A. Papapetropoulos, A. Lazou, A.-L. Skaltsounis, D. J. Hausenloy, O. Tsitsilonis, I. Tseti, F. Di Lisa, E. K. Iliodromitis, I. Andreadou, Acute administration of the olive constituent, oleuropein, combined with ischemic postconditioning increases myocardial protection by modulating oxidative defense. Free Radical Biology and Medicine, 2021, 166, 18-32, https://doi.org/10.1016/j.freeradbiomed.2021.02.011.
  29. C. Brakatselos, F. Delis, M-Z. Asprogerakas, P. Lekkas, I. Tseti, P.S. Tzimas, E.A. Petrakis, M. Halabalaki, L.A. Skaltsounis, K. Antoniou, Cannabidiol modulates the motor profile and NMDA receptor-related alterations induced by ketamine, Neuroscience 2021, 454, 105-115; https://doi.org/10.1016/j.neuroscience.2020.09.029
  30. M. Tsoumani; I. Tseti; I. Andreadou. “The usage of oleuropein on myocardium” in “Olives and Olive Oil in Health and Disease Prevention”, 2nd Edition, V. Preedy; R. Watson (eds.), Elsevier 2021, Section 3.2, p. 603-613; https://doi.org/10.1016/B978-0-12-819528-4.00016-X
  31. G. K. Markantes, K. Dimitropoulos, I. Mamali, I. Tseti, G. Sakellaropoulos, K. B. Markou, M. A. Michalaki. “Therapeutic Equivalence of a New Preparation of Liquid Levothyroxine with Tablets in Patients with Overt Primary Hypothyroidism”. Eur Thyroid J. 2021, 10, 59-64; https://doi.org/10.1159/000508216.
  32. C. Pantos, G. Kostopanagiotou, A. Armaganidis, A. Trikas, I. Tseti and I. Mourouzis. “Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial.” Trials 2020 21:573; https://doi.org/10.1186/s13063-020-04474-0.
  33. C. Pantos, I. Tseti and I. Mourouzis. “Use of Triiodothyronine to treat critically ill COVID-19 patients: a new clinical trial”. Critical Care 2020 24:209; https://doi.org/10.1186/s13054-020-02934-2
  34. I. Tseti. “Melatonin as a Food Supplement for Sleep Disorders” in “Melatonin – The Hormone of Darkness and its Therapeutic Potential and Perspectives” Marilena Vlachou (ed) IntechOpen, 2020, Chapter 3; https://doi.org/10.5772/intechopen.91410.
  35. C Fytili, A Kokkinos, C Dimosthenopoulos, D Simos, IK Tseti, M Halabalaki, N Katsilambros, N Tentolouris, LA Skaltsounis. “Effect of administration of hydroxytyrosol on weight and fat loss: preliminary data from a randomised double blind prospective study”. Planta Medica 2019; 85(18): 1559-0; https://doi.org/10.1055/s-0039-3400123
  36. T. Tsaganos, I. K. Tseti, N. Tziolos, G.-S. Soumelas, M. Koupetori, A. Pyrpasopoulou, K. Akinosoglou, C. Gogos, N. Tsokos, A. Karagiannis, S. Sympardi and E. J. Giamarellos-Bourboulis, “Randomized, controlled, multicentre clinical trial of the antipyretic effect of intravenous paracetamol in patients admitted to hospital with infection.” Br J Clin Pharmacol 2017 83:742–750; https://doi.org/10.1111/bcp.13173
  37. P. Efentakis, A. Rizakou, E. Christodoulou, A. Chatzianastasiou, M.G. López, R. León, E. Balafas, N.P.E. Kadoglou, I. Tseti, H. Skaltsa, N. Kostomitsopoulos, E.K. Iliodromitis, G. Valsami, I. Andreadou. “Saffron (Crocus sativus) intake provides nutritional preconditioning against myocardial ischemia-reperfusion injury in Wild Type and ApoE(-/-) mice: Involvement of Nrf2 activation.” Nutr. Metab. Cardiovasc. Dis. 2017 27:919-929; https://doi.org/10.1016/j.numecd.2017.08.005.
  38. N. Pippa, I. Tseti, C. Demetzos. “Innovative excipients and formulation platforms in cosmetic product series for acne (ACNOFIX®): the physiochemical characteristics of cosmeceutical vehicle.” Advanced Science, Engineering and Medicine, 2016 8:284-289; https://doi.org/10.1166/asem.2016.1861
  39. N. Pippa, G. Mountichas, I. Tseti, C. Demetzos. “Cerasomes as Innovative Excipients in Cosmetic Product “Pregnaderm Extreme Hydration Body Cream”: A Physicochemical Study.” Advanced Science, Engineering and Medicine, 2016 8:26-30; https://doi.org/10.1166/asem.2016.1799.
  40. P N Shaw, J Tseti, S Warburton, A Adedoyin, J B Houston. “Inhibition of antipyrine metabolite formation. Steady state studies with cimetidine and metyrapone in rats”. Drug Metab Dispos, 1986 14:271-6.
  41. G.Papaioannou, J Tseti, Bostrychosis: Methods and side effects 1984
Διαβάστε Περισσότερα

ΠΑΡΟΥΣΙΑΣΕΙΣ ΣΕ ΕΘΝΙΚΑ & ΔΙΕΘΝΗ ΣΥΝΕΔΡΙΑ

Προφορικές & Αναρτημένες παρουσιάσεις σε Εθνικά & Διεθνή Συνέδρια

  1. Andriana Christodoulou, Stelios Zerikiotis, Panagiota E Nikolaou, Angeliki Choustoulaki, Panagiotis Efentakis, Maria Tsoumani, Nikolaos Kostomitsopoulos, Constantinos A Dimitriou, Aimilia Varela, Constantinos H Davos, Alexios- Leandros Skaltsounis, Ioulia Tseti, Efstathios K Iliodromitis, Ioanna Andreadou. Comparative study of olive-derived bioactive compounds on cardioprotection from ischemia-reperfusion injury in mice with metabolic syndrome. CBCS Summer School by the Council on Basic Cardiovascular Science, Sophia-Atipolis France, 11-15 June 2023.
  2. E. Kostouli, A. Christodoulou, D. Benaki, N. Kostomitsopoulos, I. Tseti, L. Skaltsounis, I. Andreadou, E. Mikros. Alterations of the hepatic metabolome in response to olive oil compounds administration on metabolic syndrome. 19ο Hellenic Symposium of Medicinal Chemistry, Patra, 9-11 Μarch 2023.
  3. Andriana Christodoulou, Eva Kostouli, Panagiota-Efstathia Nikolaou, Panagiotis Efentakis, Nikolaos Kostomitsopoulos, Maria Chalampalaki, Ioulia Tseti, Leandros Skaltsounis, Dimitra Benaki, Emmanuel Mikros, Ioanna Andreadou. Study of the effect of olive bioactive components on parameters of the metabolic syndrome and investigation of the possible changes induced in the liver protein and metabolomic profile in vivo. 10th Panhellenic Congress of the Hellenic Society of Atherosclerosis, December 1-3, 2022.
  4. Andriana Christodoulou, Maria Tsoumani, Panagiota-Efstathia Nikolaou, Panagiotis Efentakis, Nikolaos Kostomitsopoulos, Kostantinos Dimitriou, Maria Chalampalaki, Ioulia Tseti, Leandros Skaltsounis, Efstathios Helioromitis, Ioanna Andreadou. Comparative study of cardioprotective action induced by bioactive substances of olive and olive oil in an in vivo model of metabolic syndrome. 10th Panhellenic Congress of the Hellenic Society of Atherosclerosis, December 1-3, 2022.
  5. A. Christodoulou, S. Zerikiotis, P. Dimas, P. Efentakis, I. Tseti, I. Andreadou. Dihydromyricetin: a natural flavonoid could prevent hepatotoxicity and nephrotoxicity induced by Methotrexate treatment. 12ο Scientific Conference of the Hellenic Society of Basic and Clinical Pharmacology, Arta, 7-9 October 2022.
  6. A. Christodoulou, P-E. Nikolaou, M. Tsoumani, P. Efentakis, S. Zerikiotis, N. Kostomitsopoulos, I. Ikonomidis, M. Halabalaki, I. Tseti, A-L. Skaltsounis, E.K. Iliodromitis, I. Andreadou. Olive-derived bioactive compounds salvage the myocardium from ischemia/reperfusion injury, via mechanisms involving apoptosis mediators and antioxidant enzymes. 12ο Scientific Conference of the Hellenic Society of Basic and Clinical Pharmacology, Arta, 7-9 October 2022.
  7. I. Antoniadou, M. Georgiou, A. Lamprou, N. Lougiakis, N. Pouli, N. Karousis, I. Tseti, P. Marakos, A. Papapetropoulos. Novel H2S-releasing bifunctional antihistamine molecules with improved antipruritic action. Scientific Conference of the Hellenic Society of Basic and Clinical Pharmacology, Arta, 7-9 October 2022.
  8. M Tsoumani, A Georgoulis, P E Nikolaou, I Kostopoulos, T Dermintzoglou, I Papatheodorou, A Zoga, P Efentakis, A Papapetropoulos, A Lazou, A L Skaltsounis, O Tsitsilonis, I Tseti, E K Iliodromitis, I Andreadou, Acute administration of the olive constituent, oleuropein, combined with post-conditioning mechanism exerts cardioprotective effects by modulating oxidative defense, European Heart Journal, Volume 42, Issue Supplement 1, October 2021, ehab724.3240, https://doi.org/10.1093/eurheartj/ehab724.3240.
  9. T. Nikou, C. Fytili, E. Kalampokis, N. Tentolouris, I. K. Tseti, L.A. Skaltsounis, M. Halabalaki. New human urine biomarkers associated with hydroxytyrosol consumption and olive-based products. Planta Med 2021; 87(15): 1244 https://doi.org/10.1055/s-0041-1736763 GA – 69th Annual Meeting 2021, Virtual conference Bonn, Germany, 05.–08.09.2021.
  10. Christodoulou A, Nikolaou PE, Tsoumani M, Efentakis P, Kostomitsopoulos N, Dimitriou CA, Ikonomidis I, Halabalaki M, Tseti I, Skaltsounis AL, Iliodromitis EK, Andreadou I. Comparative study of the bioactive compounds of olive products on cardioprotection from ischemia/reperfusion injury in mice with metabolic syndrome” ESC Congress 2021 – The Digital Experience, 27–30 August 2021.
  11. Christodoulou A, Nikolaou PE, Tsoumani M, Efentakis P, Kostomitsopoulos N, Dimitriou CA, Ikonomidis I, Halabalaki M, Tseti I, Skaltsounis AL, Iliodromitis EK, Andreadou I. Comparative study of the cardioprotective effect exerted by bioactive olive-derived compounds on ischemia-reperfusion injury in mice with metabolic syndrome. 36th ANNUAL MEETING OF THE INTERNATIONAL SOCIETY FOR HEART RESEARCH EUROPEAN SECTION, 29 June-1 July 2021.
  12. Theodora Nikou, Christina Fytili, Matthias Witt, Aiko Barsch, Nikolaos Tentolouris, Ioulia K. Tseti, Alexios-Leandros Skaltsounis, Maria Halabalaki. “From foods and foodstuffs to human biological fluids. The example of hydroxytyrosol one of the most potent natural scavenger.” 17th Annual Conference of the Metabolomics Society, 22-24 June 2021.
  13. I. Kyziropoulos, M.-E. Sakavitsi, I. K. Tseti, M. Halabalaki, A. L. Skaltsounis. “The “superstitious” Mandragora autumnalis (Solanaceae) roots, leaves and fruits after a phytochemical investigation and extended LC-HRMS & HRMS/MS characterization.” 20th International Congress of the International Society for Ethnofarmacology, Virtual Congress 18-20 April 2021. Best Poster Presentation Award.
  14. M.D. Charavgi, P. F. Karakousi, A. Papagiannopoulos, I. Tseti, S. Pispas, and E. D. Chrysina, “Structural studies of intrinsically disordered proteins foster their potential to be exploited as components of new formulations for market-oriented pharmaceutical products”, 70th HSBMB, Athens, Greece; November 29 – December 1, 2019.
  15. A. Papagiannopoulos, M-D.Charavgi, P. F. Karakousi, I. Tseti, E. D. Chrysina, and S. Pispas “Physicochemical characterization of casein micelles for nanoformulations in the food industry”, 11th International Conference on “Instrumental Methods of Analysis” (IMA-2019), Ioannina, Greece; September 22-25 2019.
  16. C. Fytili, A. Kokkinos, C. Dimosthenopoulos, D. Simos, I.K. Tseti, M. Halabalaki, L.-A. Skaltsounis, N. Katsilambros, N. Tentolouris. “Effect of the administration of hydroxytyrosol, an olive oil phenolic compound, on weight and fat loss: preliminary data from randomised double-blind prospective study.” 55th Annual Meeting of the European Association for the study of Diabetes, Barcelona, Spain, 16-20 September 2019.
  17. A. Papagiannopoulos, M-D.Charavgi, P.F. Karakousi, I. Tseti, E. D. Chrysina, and S. Pispas “Physicochemical characterization of casein micelles for nanoformulations in the food industry”, XXXVI Panhellenic Conference on Solid State Physics and Materials Science, Patras, Greece; September 11-14, 2019.
  18. C. Fytili, A. Kokkinos, C. Dimosthenopoulos, D. Simos, I.K. Tseti, M. Halabalaki, L.-A. Skaltsounis, N. Katsilambros, N. Tentolouris. “Effect of hydroxytyrosol administration, an olive oil phenolic compound, on weight and fat loss: preliminary data from a double-blind prospective study.” 37th International Symposium on Diabetes and Nutrition, Kerkrade, The Netherlands, June 12th – June 14th, 2019.
  19. A. Papagiannopoulos, M-D. Charavgi, P. F. Karakousi, I. Tseti, S. Pispas, and E.D. Chrysina, “Structural studies of intrinsically disordered proteins towards the development of formulations for market-oriented pharmaceutical products”, INSTRUCT Biannial Conference, Madrid, Spain; May 22-24 2019.
  20. Ioulia K. Tseti, Efstathia Thoma, Aikaterini Argyropoulou, Alexios-Leandros Skaltsounis. Qualitative analysis of Herbofix herbal extracts and comparison with extracts prepared by infusion using HPTLC, HPLC-DAD and UPLC-MS. 30th International Symposium on the Chemistry of Natural Products and the 10th International Congress on Biodiversity, Greece 25-29 November 2018.
  21. Hatziantoniou Sophia, Soumelas Georgios-Stefanos, Archondikis Athanasios, Tseti Ioulia, Demetzos Costas. “Thermal analysis study of the interaction between N-Acetylcysteine and excipients used in commercial pharmaceutical solid dosage forms for immediate release.” Medicta, 2013, Athens 12-15 June, P107a.
  22. Koufaki M., Calogeropoulou T., Detsi A., Kourounakis P., Rekka E., Chrysellis M., Papazafiri P., Tseti J. “Agents combining antioxidant and antiarrhythmic activity”, 9th International Conference of Pharmaceutical Technology, Berlin, 3-6 April 2000.
  23. Τσέτη Ιουλία. «Σύγκριση και αξιολόγηση δυο αναλυτικών μεθόδων δραστικού συστατικού ιδιοσκευάσματος». 1η Ημερίδα της Εταιρείας Φαρμακευτικής Τεχνολογίας Ελλάδος, Μάϊος 1989.
  24. Μ. Αγγελάκας, Α. Αρχοντίκης, Δ.Μ. Ρέκκας, Ι. Τσέτη, Ν.Η. Χούλης. «In vitro μελέτη μορφοποίησης της Νιφεδιπίνης (REANIMAT), σε σκληρές κάψουλες και δισκία». 4ο Πανελλήνιο Συνέδριο Φαρμακοποιών, Μάιος 1988.
Διαβάστε Περισσότερα

μαθετε
περισσοτερα

Press ΟΜΙΛΟΣ UNI-PHARMA ΕΠΙΚΟΙΝΩΝΙΑ
Ιουλία Τσέτη
Linked In

© 2024 ΙΟΥΛΙΑ ΤΣΕΤΗ

Back to top